show metatastic dissemination. A meticulous enucleation was carried out with an implant of hydroxyapatite coral prosthesis enveloped in donor sclera.
Macroscopic examination of the excised eye showed an encapsulated tumour of greyish appearance indenting the lens and a serous retinal detachment extending as far back as the optic disc ( Fig. 1, below) . Microscopic examination proved that the tumour was a neurilemmoma with the characteristic pattern described by Antoni. It probably took origin from Schwann cells associated with the ciliary nerves and was histologically benign (Fig. 2) .
Comment
Although the benignity of the tumour does not contraindicate enucleation in order to avoid progression to a painful blind eye, in this case enucleation was carried out in view of a possible malignant melanoma. It is known that this type of tumour may undergo accelerated growth during pregnancy and ciliary body melanomas have also been described as evolving in this way. Besides, at times they do transilluminate. Therefore, in this case the assumption of a melanoma until proven otherwise was mandatory. Even in the presence of a fine needle biopsy positive for schwannoma, the malignant potential of this tumour cannot be assessed without histological sections and the rate of growth as measured by incorporation of radioactive phosphorus is not greatly different from that of a malignant melanoma. In conclusion it seems that this condition will continue to be recognised retrospectively and treated as something different until a reliable diagnostic test is available. 
Sir,
Central retinal artery occlusion due to rapidly expand ing orbital lymphoma
The presentation of lymphoproliferative disorders affecting the orbit is usually insidious and painless. 1 The common manifestations are proptosis, blepharoptosis, diplopia, limited ocular motility and rarely decreased visual acuity. To our knowledge, this is the first report of a rapidly progressive orbital lymphoma resulting in an 
Case report
An 85-year-old man presented with a 6 day history of sudden painful swelling of his left eye and horizontal diplopia. Six months prior to presentation the patient experienced bilateral sequential seventh cranial nerve ( a ) palsies associated with headaches. His past ocular history was notable for an intracapsular cataract extraction in both eyes and a subsequent retinal detachment repair of the right eye 20 years earlier.
At presentation, visual acuity was 20/ 200 aD and 20/ 60 as with aphakic spectacle correction. There was no afferent pupillary defect of dyschromatopsia. Seven millimetres of left proptosis (Fig. la) , associated with generalised limitation of ductions and an exotropia in primary position, was present. A non-tender rubbery subcutaneous mass was palpable near the medial canthal angle, and an epibulbar subconjunctival mass was noted at the medial aspect of the left globe. The intraocular pressure was 10 mmHg aD and 27 mmHg as.
Orbital computerised tomography demonstrated a left extraconal orbital mass, displacing the medial rectus, moulding to the globe with anterior extension to the epibulbar space (Fig. Ib) .
An uncomplicated subconjunctival incisional biopsy of the epibulbar mass revealed a high-grade B-cell lymphoma, with irregular nuclei and numerous mitoses. The cells stained positively with IgG Kappa and CD20 / CD22 antibodies.
Four days after the biopsy the patient experienced a further progression of proptosis of the left eye associated with decreased vision, but neglected to seek medical consultation until his routine follow-up examination 1 week post-operatively. At that time, the left proptosis was more prominent and the vision in the left eye had decreased to 20/400. Diffuse retinal oedema sparing the macula (Fig. 2a) and choroidal folds were present in the left eye. Fluorescein angiography demonstrated filling only of the cilioretinal artery, indicating a central retinal artery occlusion (Fig. 2b) .
Anterior chamber paracentesis was performed with no immediate response. However, prompt treatment with oral corticosteroids (prednisone 80 mg/ day) resulted in dramatic improvement of the vision in the left eye to 20/ 40, reduction in proptosis and resolution of retinal oedema within 2 days. 
